Fisetin — research review 2

...So, the hype around fisetin is understandable. It's a senolytic flavonol, meaning it's been shown to clear senescent cells, which accumulate as we age. The theory is that clearing these "zombie cells" could slow down aging.

And in mice, the results were quite compelling. A study in EBioMedicine in 2018 found that fisetin was the most potent senolytic tested, and when administered to mice late in life, it extended both median and maximum lifespan.

Right. Beyond just clearing senescent cells, fisetin also activates SIRT1, as detailed in Int J Mol Sci 2017. It also boosts the Nrf2 antioxidant pathway, which helps protect cells from damage.

Plus, there's evidence from Oncotarget in 2021 suggesting it slightly inhibits the mTOR pathway, echoing some of rapamycin's gerostatic effects. It’s certainly got a multi-pronged approach in preclinical models.

But here’s the crucial point for us: while these mechanisms are exciting, human evidence is still largely in its early stages. We’re talking about preclinical data, not large-scale human clinical trials showing significant longevity benefits.

Exactly. You can get fisetin naturally from foods like strawberries, apples, and onions, which is a good thing to incorporate into a healthy diet, as noted in Nutrients 2026. But translating the mouse lifespan extension to humans, or even confirming these specific pathways have a measurable, positive impact on human aging or disease prevention, is where the evidence gets thin.

So, while the mouse data is promising, we still don't have definitive human clinical trial results proving that fisetin extends human lifespan or prevents age-related diseases. That's a huge unknown.